SIRT1 knockdown inhibited USP22-induced HCCC tumour growth (Fig. 6A), and the sizes and weights of these tumours were almost half of the HCCC-USP22 (p < 0.05) (Fig. 6B and C). Here, USP22 is linked to neoplasm.